Tolerance to Stimulant Medication for Attention Deficit Hyperactivity Disorder: Literature Review and Case Report

Tolerance to Stimulant Medication for Attention Deficit Hyperactivity Disorder: Literature Review and Case Report

Recommended treatment for attention deficit hyperactivity disorder (ADHD) includes stimulant medication. While these medicines are effective for most ADHD patients, benefits may wear off, suggesting tolerance. This paper reviews the published literature on tolerance to stimulant medication treatment...

Full description

Bibliographic Details
Main Authors:	Kenneth Handelman, Fernando Sumiya
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Brain Sciences
Subjects:	stimulant medication ADHD tolerance methylphenidate amphetamines
Online Access:	https://www.mdpi.com/2076-3425/12/8/959

Similar Items

Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers
by: Claire Diane Advokat, et al.
Published: (2013-05-01)

Finding the “Sweet Spot”: Sharing the decision-making in ADHD treatment selection
by: Daniel Tan, et al.
Published: (2022-05-01)

Attention-deficit/hyperactivity disorder
by: A. M.E. du Plessis
Published: (2015-05-01)

Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder?
by: Johanne Pereira Ribeiro, et al.
Published: (2021-08-01)

Quality of life in a sample of schoolchildren with attention deficit and hyperactivity disorder
by: S. Pérez Sánchez, et al.
Published: (2021-04-01)

A Quasi-Experimental Trial in Comparison of Duloxetine and Methylphenidate in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder
by: Nasrin Dodangi, et al.
Published: (2016-06-01)

Practical clinical guidelines and pharmacological treatment for attention‐deficit hyperactivity disorder in Asia
by: Kentaro Kawabe, et al.
Published: (2024-03-01)

Decreased Risk of Influenza in Child and Adolescent Patients with Attention-Deficit Hyperactivity Disorder Following Methylphenidate Treatment: A Nationwide Cohort Study in Taiwan
by: Lee H, et al.
Published: (2020-05-01)

A review of Cochrane reviews on pharmacological treatment for attention deficit hyperactivity disorder
by: Giovanna Marcílio Santos, et al.
Published: (2021-12-01)

Attention deficit hyperactivity disorder - symptoms, diagnosis and therapy among children and adults.
by: Agata Surowiec, et al.
Published: (2023-08-01)

Attention Deficit Hyperactivity Disorder and Methylphenidate: When Society Misunderstands Medicine
by: David D. Kaminester
Published: (2020-12-01)

Decrease in brain complexity with methylphenidate treatment in boys diagnosed with attention deficit hyperactivity disorder: An entropy-based qeeg analysis
by: F.H. Çetin, et al.
Published: (2021-04-01)

Prescribing patterns for attention deficit hyperactivity disorder among children and adolescents in Taiwan from 2004 to 2017
by: Heng-Ching Liao, et al.
Published: (2023-06-01)

Adverse Effects of Medications for ADHD: Priapism with Medication for ADHD
by: J Gordon Millichap, et al.
Published: (2014-08-01)

Review and Meta-analysis on the Impact of the ADRA2A Variant rs1800544 on Methylphenidate Outcomes in Attention-Deficit/Hyperactivity Disorder
by: Daniel T. Hain, et al.
Published: (2022-04-01)

Increase in brain connectivity with methylphenidate treatment in boys diagnosed with attention deficit hyperactivity disorder: A coherence-based qeeg analysis
by: F.H. Çetin, et al.
Published: (2021-04-01)

Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice
by: Sunsha Chamakalayil, et al.
Published: (2021-01-01)

Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder
by: Anne B. Arnett, et al.
Published: (2022-05-01)

Effectiveness of Psychostimulant and Non-Psychostimulant Drug Therapy in the Attention Deficit Hyperactivity Disorder
by: Adriana Cojocaru, et al.
Published: (2021-01-01)

Methylphenidate-Induced Raynaud’s Phenomenon In Two Cases With Attention-Deficit/Hyperactivity Disorder
by: Ömer Faruk Akça, et al.
Published: (2021-05-01)

Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder
by: Ali Karayağmurlu, et al.
Published: (2022-09-01)

Effects of methylphenidate on height, weight and blood biochemistry parameters in prepubertal boys with attention deficit hyperactivity disorder: an open label prospective study
by: Çevikaslan Ahmet, et al.
Published: (2021-01-01)

Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status
by: Huang Yu-Shu, et al.
Published: (2012-11-01)

Viloxazine: A New Non-Stimulant Treatment for Attention-Deficit/Hyperactivity Disorder (ADHD)
by: Wiktoria, et al.
Published: (2024-02-01)

Advances and Considerations in Attention-Deficit/Hyperactivity Disorder Pharmacotherapy
by: Shahin Akhondzadeh, et al.
Published: (2011-08-01)

Secular trends and regional variations in pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in Germany
by: Manas K. Akmatov, et al.
Published: (2021-08-01)

Trends in characteristics of the recipients of new prescription stimulants between years 2010 and 2020 in the United States: An observational cohort study
by: Shannon Brumbaugh, et al.
Published: (2022-08-01)

The use of attention-deficit hyperactivity disorder medications in cardiac disease
by: Constantin-Cristian Topriceanu, et al.
Published: (2022-10-01)

A retrospective medical chart review of clinical outcomes in children and adolescents with attention-deficit/hyperactivity disorder treated with guanfacine extended-release in routine Canadian clinical practice
by: Judy van Stralen, et al.
Published: (2021-10-01)

A comparison of effectiveness of regulation of working memory function and methylphenidate on remediation of attention deficit hyperactivity disorder (ADHD).
by: Mohammad Reza Mohammadi, et al.
Published: (2014-03-01)

Are psychiatric comorbidities and associated cognitive functions related to treatment response to methylphenidate in boys with attention-deficit/hyperactivity disorder?
by: Chan MH, et al.
Published: (2017-04-01)

Análise da eficácia do metilfenidato usando a versão abreviada do questionário de conners em transtorno de déficit de atenção/hiperatividade Analysis of the methylphenidate's efficacy using the abbreviated version Conners' questionnaire in attention deficit hyperactivity disorder
by: Ênio Roberto de Andrade, et al.
Published: (2004-03-01)

Efficacy of stimulants for preschool attention‐deficit/hyperactivity disorder: A systematic review and meta‐analysis
by: Luisa S. Sugaya, et al.
Published: (2023-09-01)

NIRS Hemodynamic Response to Methylphenidate in Children with Attention Aeficit Hyperactivity Disorder: First Administration, Titration Phase and Associations with Clinical Severity
by: A. Crippa, et al.
Published: (2022-06-01)

Ritalin Abuse and its Complications
by: َAmir Reza Katebi, et al.
Published: (2017-04-01)

Case report: Methylphenidate improved chronic pain in an adult patient with attention deficit hyperactivity disorder
by: Ekachaeryanti Zain, et al.
Published: (2023-03-01)

Is it Attention Deficit Hyperactivity Disorder (ADHD) or Stimulant use disorder ? How is ADHD diagnosed?
by: N. Sud
Published: (2022-06-01)

The Impact of Persistent Irritability on the Medication Treatment of Paediatric Attention Deficit Hyperactivity Disorder
by: Raman Baweja, et al.
Published: (2021-07-01)

The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder
by: A Schrantee, et al.
Published: (2017-01-01)

Comparison of Stimdate with Ritalin in Children and Adolescents with Attention Deficit Hyperactivity Disorder: a Double-Blind, Randomized Clinical Trial
by: Najmeh Khosrovan Mehr, et al.
Published: (2009-02-01)